Early health technology assessment: current and future perspectives from a health technology assessment agency [0.03%]
早期卫生技术评估：来自卫生技术评估机构的现状和未来展望
David Jarrom
David Jarrom
Health technology assessment (HTA) can occur at different stages of a technology's lifecycle. In the accompanying paper, Grutters and colleagues present a consensus definition of "early HTA" as a health technology assessment conducted to in...
The use of real-world evidence among healthcare payers: a scoping review [0.03%]
真实世界证据在医疗保健支付方中的应用：系统综述
Lisa Masucci,Diedron Lewis,Jiahao Zhao et al.
Lisa Masucci et al.
Introduction: Real-world evidence (RWE) is increasingly used to assess and make regulatory decisions on health technologies. However, its application in healthcare payer decision-making is less well-known. ...
Methods used in early value assessments for nice: a scoping review [0.03%]
nice早期价值评估中方法的应用：一项题录检索式回顾
Eugenie Evelynne Johnson,Giovany Orozco-Leal,Madeleine Still et al.
Eugenie Evelynne Johnson et al.
Objectives: The National Institute for Health and Care Excellence (NICE) in England introduced early value assessments (EVAs) as an evidence-based method of accelerating access to promising health technologies that could ...
Hannah O&#x;Keefe,Elizabeth Green,Anjum Jahan et al.
Hannah O&#x;Keefe et al.
The UK Early Access to Medicines Scheme: uptake, approvals and reimbursement [0.03%]
英国早期获取药品计划：采用情况、审批和补偿政策研究
Christopher Felix Brewer
Christopher Felix Brewer
Assessment of Medical Device Features in Health Technology Assessment: A Review of NICE Medical Technology Guidance [0.03%]
英国NICE医疗科技评估中技术特征评价回顾分析
Stine Pearson,Liana Andrusjaka,Mark Campbell et al.
Stine Pearson et al.
Constraints on Delivering Cell and Gene Therapies Identified during Technology Appraisal by the National Institute for Health and Care Excellence [0.03%]
英国国家卫生与保健优化研究所技术评估中确定的实施细胞和基因治疗的限制因素
Harshini Hariram,Sean Gavan
Harshini Hariram
Plain Language Summaries Supporting Patient Involvement. Lessons and Guidance from HTAi Patients and Citizen Involvement Interest Group (PCIG) [0.03%]
浅显语言摘要支持患者参与：HTAi患者及公民参与兴趣小组(PACIG)的经验与启示
Martin Andrew Coombes,Kate Morgan,Jose Diaz et al.
Martin Andrew Coombes et al.
Linda Mundy,Guy Maddern
Linda Mundy